Elocta-003 ITI Study

Study NameStudy TitleStudy TypeSponsorSponsor Type
Elocta-003 ITI StudyA Non-Controlled, Open-Label, Multicenter, Study of Immune Tolerance Induction Performed with rFVIIIFc within a Timeframe of 60 Weeks in Severe Haemophilia A Patients with Inhibitors who have Failed Previous Immune Tolerance Induction TherapiesClinical Trial of IMPSobi (Swedish Orphan Biovitrum AB)Industry Sponsored